Back
Verint Systems Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
31
VRNT
Verint Systems
Last Price:
26.37
Seasonality Move:
2.78%
Sell
25
ALNY
Alnylam Pharmaceuticals
Last Price:
265.13
Seasonality Move:
5.61%
Sell
31
Verint Systems (VRNT)
is a Sell
Is Verint Systems a Buy, Sell or Hold?
- The current Verint Systems [VRNT] share price is $26.38. The Score for VRNT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- VRNT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $265.27. The Score for ALNY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRNT Stock Price Chart
What is Verint Systems's stock price today?
-
The Verint Systems share price today is $26.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRNT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $265.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRNT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.94 | Sell |
Relative Strength Index (14 RSI): | 31.39 | Sell |
Chaikin Money Flow: | 932487 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.5 - 33.26) | Sell |
Bollinger Bands (100): | (29.58 - 34.58) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 53.6 | Buy |
Chaikin Money Flow: | 403934 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (256.2 - 277.22) | Sell |
Bollinger Bands (100): | (158.9 - 265.08) | Buy |
VRNT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.46 | Sell |
20-day SMA: | 29.99 | Sell |
50-day SMA: | 31.84 | Sell |
200-day SMA: | 30.68 | Sell |
8-day EMA: | 26.84 | Sell |
20-day EMA: | 29 | Sell |
50-day EMA: | 30.94 | Sell |
200-day EMA: | 31.2 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 256.17 | Buy |
20-day SMA: | 266.77 | Sell |
50-day SMA: | 258.27 | Buy |
200-day SMA: | 189.51 | Buy |
8-day EMA: | 260.57 | Buy |
20-day EMA: | 261.96 | Buy |
50-day EMA: | 250.03 | Buy |
200-day EMA: | 205.35 | Buy |
Verint Systems Earnings Growth & VRNT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.17 per share, an increase this year of $0.15 per share, and an increase next year of $0.26 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Verint Systems Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |